Androgen receptor CAG repeat polymorphisms in canine prostate cancer

Journal of Veterinary Internal Medicine

Volumn 22, Issue 6, 2008, Pages 1380-1384

  Lai, C L ^a   L'Eplattenier, H ^a   Van Den Ham, R ^a   Verseijden, F ^a   Jagtenberg, A ^a   Mol, J A ^a   Teske, Erik ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Androgen resistance; Breed specificity; Haplotype; Progression; Transactivation domain

Indexed keywords

ANDROGEN RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MALE; PROSTATE TUMOR;

ANIMALS; DOG DISEASES; DOGS; GENETIC PREDISPOSITION TO DISEASE; MALE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

ANIMALIA; CANIS FAMILIARIS;

EID: 57149113372     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0181.x     Document Type: Article

References (36)

1. Niu YJ, Ma TX, Zhang J, et al. Androgen and prostatic stroma. Asian J Androl 2003;5:19-26.
2. Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev 2004;25:276-308.
3. Dorgan JF, Judd JT, Longcope C, et al. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: A controlled feeding study. Am J Clin Nutr 1996;64:850-855.
4. Gann PH, Hennekens CH, Ma J, et al. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996;88:1118-1126.
5. Noble RL. Sex steroids as a cause of adenocarcinoma of the dorsal prostate in Nb rats, and their influence on the growth of transplants. Oncology 1977;34:138-141.
6. Algarte-Genin M, Cussenot O, Costa P. Prevention of prostate cancer by androgens: Experimental paradox or clinical reality. Eur Urol 2004;46:285-294.
7. van der Kwast TH, Schalken J, Ruizeveld de Winter JA, et al. Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int J Cancer 1991;48:189-193.
8. Culig Z, Hobisch A, Hittmair A, et al. Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate 1998;35:63-70.
9. Edwards J, Krishna NS, Grigor KM, et al. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer 2003;89:552-556.
10. Edwards A, Hammond HA, Jin L, et al. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992;12:241-253.
11. Hsing AW, Gao YT, Wu G, et al. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China. Cancer Res 2000;60:5111-5116.
12. Stanford JL, Just JJ, Gibbs M, et al. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk. Cancer Res 1997;57:1194-1198.
13. Vijayalakshmi K, Thangaraj K, Rajender S, et al. GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men. J Hum Genet 2006;51:998-1005.
14. Waters DJ, Patronek GJ, Bostwick DG, et al. Comparing the age at prostate cancer diagnosis in humans and dogs. J Natl Cancer Inst 1996;88:1686-1687.
15. Cornell KK, Bostwick DG, Cooley DM, et al. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: A retrospective analysis of 76 cases. Prostate 2000;45:173-183.
16. Waters DJ, Sakr WA, Hayden DW, et al. Workgroup 4: Spontaneous prostate carcinoma in dogs and nonhuman primates. Prostate 1998;36:64-67.
17. Johnston SD, Kamolpatana K, Root-Kustritz MV, et al. Prostatic disorders in the dog. 2000;60-61:405-415.
18. Teske E, Naan EC, van Dijk EM, et al. Canine prostate carcinoma: Epidemiological evidence of an increased risk in castrated dogs. Mol Cell Endocrinol 2002;197:251-255.
19. Lai CL, van den Ham R, van Leenders G, et al. Histopathological and immunohistochemical characterization of canine prostate cancer. Prostate 2008;68:477-488.
20. Lu B, Smock SL, Castleberry TA, et al. Molecular cloning and functional characterization of the canine androgen receptor. Mol Cell Biochem 2001;226:129-140.
21. Shibuya H, Nonneman DJ, Huang TH, et al. Two polymorphic microsatellites in a coding segment of the canine androgen receptor gene. Anim Genet 1993;24:345-348.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
23. Hedrick P, Kumar S. Mutation and linkage disequilibrium in human mtDNA. Eur J Hum Genet 2001;9:969-972.
24. Balic I, Graham ST, Troyer DA, et al. Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men. J Urol 2002;168:2245-2248.
25. Mishra D, Thangaraj K, Mandhani A, et al. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet 2005;68:55-60.
26. Sieh W, Edwards KL, Fitzpatrick AL, et al. Genetic susceptibility to prostate cancer: Prostate-specific antigen and its interaction with the androgen receptor (United States). Cancer Causes Control 2006;17:187-197.
27. Gao T, Marcelli M, McPhaul MJ. Transcriptional activation and transient expression of the human androgen receptor. J Steroid Biochem Mol Biol 1996;59:9-20.
28. Platz EA, Leitzmann MF, Rifai N, et al. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev 2005;14:1262-1269.
29. Edwards SM, Badzioch MD, Minter R, et al. Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival. Int J Cancer 1999;84:458-465.
30. Chen C, Lamharzi N, Weiss NS, et al. Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomarkers Prev 2002;11:1033-1040.
31. Salinas CA, Austin MA, Ostrander EO, et al. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk. Prostate 2005;65:58-65.
32. Giovannucci E. Is the androgen receptor CAG repeat length significant for prostate cancer? Cancer Epidemiol Biomarkers Prev 2002;11:985-986.
33. Zeegers MP, Kiemeney LA, Nieder AM, et al. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 2004;13:1765-1771.
34. Lange EM, Sarma AV, Ray A, et al. The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: Results from the Flint Men's health study. J Hum Genet 2008;53:220-226.
35. Bennett CL, Price DK, Kim S, et al. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status. J Clin Oncol 2002;20:3599-3604.
36. Bryan JN, Keeler MR, Henry CJ, et al. A population study of neutering status as a risk factor for canine prostate cancer. Prostate 2007;67:1174-1181.